Evidence map›Paper›PMID 40760493›Full record

ArticleCell communication and signaling : CCS2025

Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition.

Chengyu Li, Chen Fu, Wenhan Zhou, Hongmin Li, Zhaojun Liu, Gang Wu, Tong He, Ming Shen, Honglin Liu

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. P53 Competitively Binds P300 to Suppress HIF-1α/TFRC-Mediated Ferroptosis and Promote Doxorubicin Resistance in Breast Cancer.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chengyu Li *College of Animal Science and Technology, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China.
Chen Fu *College of Animal Science and Technology, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China.
Wenhan ZhouCollege of Animal Science and Technology, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China.
Hongmin LiCollege of Animal Science and Technology, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China.
Zhaojun LiuCollege of Animal Science and Technology, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China.
Gang WuCollege of Animal Science and Technology, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China.
Tong HeCollege of Animal Science and Technology, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China.
Ming ShenCollege of Animal Science and Technology, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China. shenm2015@njau.edu.cn.
Honglin LiuCollege of Animal Science and Technology, Nanjing Agricultural University, Weigang 1, Nanjing, 210095, China. liuhonglin@njau.edu.cn.

Funding

China Postdoctoral Science Foundation 2022M721650Fundamental Research Funds for the Central Universities KJYQ2025002"JBGS" Project of Seed Industry Revitalization in Jiangsu Province JBGS (2021) 026Jiangsu Agricultural Science and Technology Innovation Fund CX (20) 2011Jiangsu Funding Program for Excellent Postdoctoral Talent 2023ZB300National Natural Science Foundation of China 31972564National Natural Science Foundation of China 32302741National Outstanding Youth Science Fund Project of National Natural Science Foundation of China 31972571Natural Science Foundation of Jiangsu Province BK20221512Natural Science Foundation of Jiangsu Province BK20230998the STI2030-Major projects 2023ZD0407106
6 · The paper itself

Abstract

Hypoxia-inducible factor 1α (HIF-1α) is a master regulator of cellular adaptation to hypoxia. Although prolyl hydroxylation-mediated degradation via the von Hippel-Lindau (VHL) ubiquitination complex is a well-established regulatory mechanism, the role of lactate-induced posttranslational modifications in HIF-1α stabilization remains incompletely understood. Here, we demonstrate that lactate induces lysine lactylation of HIF-1α at distinct residues across species-specifically, K644 in mice and K12 in humans and pigs-to increase protein stability by impairing VHL recognition. Mass spectrometry and mutagenesis analyses revealed that lactylation at these sites reduces K48-linked ubiquitination and proteasomal degradation, even when HIF-1α is hydroxylated. Structural modeling and functional assays revealed that lactylation sterically hinders VHL binding without affecting hydroxylation. Notably, lactylated HIF-1α exhibited increased transcriptional activity, as evidenced by increased promoter occupancy and upregulation of hypoxia-responsive genes (Vegfa, Glut1). Cross-species comparisons highlighted evolutionary divergence in lactylation sites while preserving the functional conservation of this modification. Our findings reveal that lactylation is a universal regulatory mechanism that overrides classical hydroxylation-dependent degradation, expanding our understanding of metabolic control over hypoxic signaling.

Indexed as

Hypoxia-Inducible Factor 1, alpha SubunitProtein Processing, Post-TranslationalVon Hippel-Lindau Tumor Suppressor ProteinAnimalsHEK293 CellsHumansHydroxylationMiceProtein BindingProtein StabilitySwineUbiquitinationHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitVHL protein, humanVon Hippel-Lindau Tumor Suppressor ProteinDegradationHIF-1αHydroxylationLactateLactylationUbiquitinationVHL

Identifiers

PMID40760493
PMCPMC12323271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.